Salvage chemotherapy in recurrent head and neck cancer: the Institut Gustave Roussy experience.
Armand
J P
JP
Institut Gustave Roussy, Villejuif, France.
Cvitkovic
E
E
Recondo
G
G
Wibault
P
P
Schwaab
G
G
Domenge
C
C
Tellez-Bernal
E
E
Gandia
D
D
Luboinski
B
B
Eschwege
F
F
D000368:Aged; D000970:Antineoplastic Agents / Q000145:classification / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D002945:Cisplatin / Q000627:therapeutic use*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D009367:Neoplasm Staging; D011379:Prognosis; D016879:Salvage Therapy / Q000379:methods*
D000970:Antineoplastic Agents; D002945:Cisplatin